---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-003575"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T05:20:09.162589+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals raises ~$5.0M in public offering of stock and warrants

## Summary
- Offering of 325,000 shares, 3,627,570 pre-funded warrants, and 3,952,570 common warrants.
- Combined purchase price: $1.265 per share+common warrant, $1.264 per pre-funded+common warrant.
- Gross proceeds ~$5.0M; net proceeds for working capital and general corporate purposes.
- Common warrants exercisable at $1.14 for 5 years; pre-funded warrants at $0.001.
- Company agreed to 45-day no-issuance and 180-day no variable-rate transaction lock-up.

## SEC filing metadata
- accession: 0001683168-25-003575
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316825003575/0001683168-25-003575-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316825003575/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-003575
- JSON: https://secwatch.observer/filing/0001683168-25-003575.json
- Plain text: https://secwatch.observer/filing/0001683168-25-003575.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.